戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rmophilus does not affect its sensitivity to capreomycin.
2 esistance to the tuberactinomycin antibiotic capreomycin.
3 odification that underpin Mtb sensitivity to capreomycin.
4  to 2 mug/ml), kanamycin (0.25 to 2 mug/ml), capreomycin (0.5 to 4 mug/ml), linezolid (0.25 to 2 mug/
5 ed susceptibility for phleomycin, bleomycin, capreomycin, amikacin, kanamycin, cetylpyridinium chlori
6 th despite treatment with a regimen based on capreomycin, aminosalicylic acid, or both).
7 r levofloxacin, 100% for amikacin, 97.4% for capreomycin, and 88.9% for ethionamide.
8 moxifloxacin), 99.2% for amikacin, 99.2% for capreomycin, and 96.4% for kanamycin.
9 r drugs studied were levofloxacin, amikacin, capreomycin, and ethionamide.
10 in, and kanamycin and the cyclic polypeptide capreomycin are all widely used in second-line therapy f
11 e, and at least 1 of amikacin, kanamycin, or capreomycin based on drug susceptibility test results fr
12                                      Optimal capreomycin binding and Mtb ribosome inhibition requires
13  (OFX), amikacin (AMK), kanamycin (KAN), and capreomycin (CAP) using MGIT 960 and WHO-recommended cri
14 berculostatic macrocyclic peptide antibiotic capreomycin IB has been accomplished.
15                                              Capreomycin is a potent ribosome-targeting antibiotic th
16 reptomycin, ethambutol, amikacin, kanamycin, capreomycin, ofloxacin, moxifloxacin, ethionamide, para-
17 hambutol, streptomycin, amikacin, kanamycin, capreomycin, ofloxacin, moxifloxacin, ethionamide, para-
18 ing Mtb gene tlyA, which cause resistance to capreomycin, our current structural and mechanistic unde
19 of 16S rRNA, the site of previously reported capreomycin resistance base substitutions.
20                                              Capreomycin resistance in other bacteria has been shown
21       A spontaneous kanamycin resistance and capreomycin resistance mutation, A1408G, in the decoding
22 losis drugs tested, 11 were monoresistant to capreomycin, rifampin, isoniazid (INH), pyrazinamide, or
23        Despite the important role of TlyA in capreomycin sensitivity and identification of inactivati
24 ch their isolate was susceptible, especially capreomycin sulfate, and among patients with a CD4+ T-ly
25 acin was 1.5 microg/ml, that established for capreomycin was 3.0 microg/ml, and that established for

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。
 
コーパス検索結果について
ご利用ガイド
ご利用規定
新規対訳・お問い合わせ
Copyright 1993 - ライフサイエンス辞書プロジェクト